About: FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.71 (-15.06%)
FBLG NASDAQ FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. Common Stock share price
Atividade de preço de FBLG
Último preço
$ 0,830
Variação (24h)
-0,01 USD (1,19%)
Volume
25.68K
Volume (média 4 sem.)
-
Abertura
$ 0,81
Variação do dia
$ 0,81 - $ 0,89
Fechamento anterior
$ 0,84
Último negócio
19 Nov, 9:00 pm GMT+0
Atrasado
19 Nov, 9:00 pm GMT+0
FBLG price performance
Atrasado
19 Nov, 9:00 pm GMT+0
FBLG details
quote.marketSignals